首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Journal of enzyme inhibition and medicinal chemistry

缩写:J ENZYM INHIB MED CH

ISSN:1475-6366

e-ISSN:1475-6374

IF/分区:5.4/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引2866
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Victor Sebastian-Perez,Alfonso García-Rubia,Sayed H Seif El-Din et al. Victor Sebastian-Perez et al.
A previous phenotypic screening campaign led to the identification of a quinazoline derivative with promising in vitro activity against Schistosoma mansoni. Follow-up studies of the antischistosomal potential of this candidate are presented...
Mikhail Krasavin,Raivis Žalubovskis,Aiga Grandāne et al. Mikhail Krasavin et al.
The hypothesis that sulfocoumarin acting as inhibitors of human carbonic anhydrase (CA, EC 4.2.1.1) cancer-associated isoforms hCA IX and - hCA XII is being able to also inhibit thioredoxin reductase was verified and confirmed. The dual tar...
Stane Pajk,Damijan Knez,Urban Košak et al. Stane Pajk et al.
Brain butyrylcholinesterase (BChE) is an attractive target for drugs designed for the treatment of Alzheimer's disease (AD) in its advanced stages. It also potentially represents a biomarker for progression of this disease. Based on the cry...
Hasan Küçükbay,Nesrin Buğday,F Zehra Küçükbay et al. Hasan Küçükbay et al.
A series of amino acid-sulphonamide conjugates was prepared through benzotriazole mediated coupling reactions and characterised by 1H-NMR, 13C-NMR, MS, and FTIR spectroscopic techniques as well as elemental analysis. The carbonic anhydrase ...
David Malinak,Rafael Dolezal,Vendula Hepnarova et al. David Malinak et al.
The series of symmetrical and unsymmetrical isoquinolinium-5-carbaldoximes was designed and prepared for cholinesterase reactivation purposes. The novel compounds were evaluated for intrinsic acetylcholinesterase (AChE) or butyrylcholineste...
Jing-Wei Liang,Shi-Long Li,Shan Wang et al. Jing-Wei Liang et al.
C-Met plays a crucial role in the development and progression of neoplastic disease. Type II c-Met inhibitors recognise the inactive DFG-out conformation of the kinase, result in better anti-tumour effects due to synergistic effect against ...
Xin Wang,Kaiyuan Deng,Cheng Wang et al. Xin Wang et al.
A novel series of cyclin-dependent kinases (CDKs) inhibitors, which play critical roles in the cell cycle control and regulation of cell transcription, were synthesised. A systematic study of enzymatic and cellular assays led to the identif...
Nabih Lolak,Mehmet Boga,Muhammed Tuneg et al. Nabih Lolak et al.
A series of 16 novel benzenesulfonamides incorporating 1,3,5-triazine moieties substituted with aromatic amines, dimethylamine, morpholine and piperidine were investigated. These compounds were assayed for antioxidant properties by using 1,...
Ivana Šagud,Nikolina Maček Hrvat,Ana Grgičević et al. Ivana Šagud et al.
The enzymes acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) are primary targets in attenuating the symptoms of neurodegenerative diseases. Their inhibition results in elevated concentrations of the neurotransmitter acetylcholin...